CRIM-negative infantile Pompe disease: Characterization of immune responses in patients treated with ERT monotherapy

PURPOSE: Enzyme replacement therapy (ERT) with recombinant human GAA (rhGAA) prolongs survival in infantile Pompe disease (IPD). However, the majority of cross reactive immunologic material (CRIM)-negative (CN) patients have immune responses with significant clinical decline despite continued ERT. W...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Genet Med
Huvudupphovsmän: Berrier, Kathryn L., Kazi, Zoheb B., Prater, Sean N., Bali, Deeksha S., Goldstein, Jennifer, Stefanescu, Mihaela C., Rehder, Catherine W., Botha, Eleanor G., Ellaway, Carolyn, Bhattacharya, Kaustuv, Tylki-Szymanska, Anna, Karabul, Nesrin, Rosenburg, Amy S., Kishnani, Priya S.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2015
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4561024/
https://ncbi.nlm.nih.gov/pubmed/25741864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gim.2015.6
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk